BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ercolani G, Zanello M, Serenari M, Cescon M, Cucchetti A, Ravaioli M, Del Gaudio M, D'Errico A, Brandi G, Pinna AD. Ten-Year Survival after Liver Resection for Breast Metastases: A Single-Center Experience. Dig Surg 2018;35:372-80. [PMID: 29393171 DOI: 10.1159/000486523] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Bale R, Putzer D, Schullian P. Local Treatment of Breast Cancer Liver Metastasis.Cancers (Basel). 2019;11. [PMID: 31514362 DOI: 10.3390/cancers11091341] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 10.7] [Reference Citation Analysis]
2 Chen Y, Guan Y, Wang J, Ma F, Luo Y, Chen S, Zhang P, Li Q, Cai R, Li Q, Mo H, Fan Y, Zhao W, Xu B. Comparison of capecitabine-based regimens with platinum-based regimens in Chinese triple-negative breast cancer patients with liver metastasis. Ann Transl Med 2021;9:109. [PMID: 33569411 DOI: 10.21037/atm-20-4590] [Reference Citation Analysis]
3 Cuyún Carter G, Mohanty M, Stenger K, Morato Guimaraes C, Singuru S, Basa P, Singh S, Tongbram V, Kuemmel S, Guarneri V, Tolaney SM. Prognostic Factors in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative (HR+/HER2-) Advanced Breast Cancer: A Systematic Literature Review. Cancer Manag Res 2021;13:6537-66. [PMID: 34447271 DOI: 10.2147/CMAR.S300869] [Reference Citation Analysis]
4 Orlandi A, Pontolillo L, Mele C, Pasqualoni M, Pannunzio S, Cannizzaro MC, Cutigni C, Palazzo A, Garufi G, Vellone M, Ardito F, Franceschini G, Sanchez AM, Cassano A, Giuliante F, Bria E, Tortora G. Liver Metastasectomy for Metastatic Breast Cancer Patients: A Single Institution Retrospective Analysis. J Pers Med 2021;11:187. [PMID: 33800160 DOI: 10.3390/jpm11030187] [Reference Citation Analysis]
5 Altundag K. A Positive Conversion in HER2 Status Might Affect Survival after Liver Resection for Breast Cancer Metastases. Dig Surg 2019;36:89. [PMID: 29502120 DOI: 10.1159/000487606] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
6 Galiandro F, Agnes S, Moschetta G, Orlandi A, Clarke G, Bria E, Franceschini G, Treglia G, Giovinazzo F. Prognostic Factors in Patients with Breast Cancer Liver Metastases Undergoing Liver Resection: Systematic Review and Meta-Analysis. Cancers 2022;14:1691. [DOI: 10.3390/cancers14071691] [Reference Citation Analysis]
7 Westphal T, Gampenrieder SP, Rinnerthaler G, Greil R. Cure in metastatic breast cancer. Memo 2018;11:172-9. [PMID: 30220923 DOI: 10.1007/s12254-018-0426-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
8 Grazi GL. Renewed considerations on the utility (or the futility) of hepatic resections for breast cancer liver metastases. Hepatobiliary Surg Nutr 2021;10:49-58. [PMID: 33575289 DOI: 10.21037/hbsn.2019.07.12] [Reference Citation Analysis]
9 Barberi V, Pietragalla A, Franceschini G, Marazzi F, Paris I, Cognetti F, Masetti R, Scambia G, Fabi A. Oligometastatic Breast Cancer: How to Manage It? J Pers Med 2021;11:532. [PMID: 34207648 DOI: 10.3390/jpm11060532] [Reference Citation Analysis]
10 Ercolani G. A Positive Conversion of Hormone Receptor Status Might Improve Survival after Liver Resection for Breast Metastases: Reply to Dr. Altundag. Dig Surg 2019;36:90. [PMID: 29597207 DOI: 10.1159/000488218] [Reference Citation Analysis]
11 Lucidi V, Bohlok A, Liberale G, Bez M, Germanova D, Bouazza F, Demetter P, Larsimont D, Aftimos P, Smoll NR, Donckier V. Extended time interval between diagnosis and surgery does not improve the outcome in patients operated for resection or ablation of breast cancer liver metastases. Eur J Surg Oncol 2020;46:229-34. [PMID: 31677938 DOI: 10.1016/j.ejso.2019.10.016] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
12 Ratti F, Serenari M, Zanello M, Prosperi E, Cipriani F, Ercolani G, Jovine E, Cescon M, Aldrighetti L. Appraisal of disease-specific benefits of minimally invasiveness in surgery of breast cancer liver metastases. J Surg Oncol 2019;120:1169-76. [PMID: 31502270 DOI: 10.1002/jso.25702] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
13 Rahnemai-Azar AA, Selby LV, Lustberg MB, Pawlik TM. Surgical Management of Breast Cancer Liver Metastasis. Surg Oncol Clin N Am 2021;30:27-37. [PMID: 33220807 DOI: 10.1016/j.soc.2020.09.003] [Reference Citation Analysis]